Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Boston Scientific ( BSX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.8%. By the end of trading, Boston Scientific fell $0.10 (-1.0%) to $9.54 on light volume. Throughout the day, 12,079,670 shares of Boston Scientific exchanged hands as compared to its average daily volume of 19,180,000 shares. The stock ranged in price between $9.51-$9.68 after having opened the day at $9.64 as compared to the previous trading day's close of $9.64. Other companies within the Health Services industry that declined today were: GenMark Diagnostics ( GNMK), down 12.8%, Pingtan Marine Enterprise ( PME), down 10.3%, CardioNet ( BEAT), down 7.7% and BG Medicine ( BGMD), down 7.6%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $12.8 billion and is part of the health care sector. Shares are up 66.0% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.

On the positive front, USMD Holdings ( USMD), down 26.2%, CombiMatrix Corporation ( CBMX), down 16.1%, Staar Surgical ( STAA), down 11.0% and Edap TMS ( EDAP), down 7.8% , were all gainers within the health services industry with UnitedHealth Group ( UNH) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Automakers Slump as Trump Launches National Security Probe into US Car Imports

Automakers Slump as Trump Launches National Security Probe into US Car Imports

Deutsche Bank Confirms Massive Job Cuts as New CEO Christian Sewing Plants Flag

Deutsche Bank Confirms Massive Job Cuts as New CEO Christian Sewing Plants Flag

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market